KREBS BIOCHEMICALS & INDUSTRIES Share Price

₹ 55.17

-₹1.43 (-2.53%)
1D
Last updated 02 Nov, 2026, 15:29 IST
NSE: KREBSBIO
|
Pharmaceuticals

KREBS BIOCHEMICALS & INDUSTRIES Share Price Today

As of 3 Nov 2026, KREBS BIOCHEMICALS & INDUSTRIES share price is ₹55.17. The stock opened at ₹56.61, compared to its previous close of ₹56.60. During today's trading session, KREBS BIOCHEMICALS & INDUSTRIES share price moved in the range of ₹53.40 to ₹57.69, with an average price of ₹55.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹38.33 and a high of ₹76.85. On the performance front, KREBS BIOCHEMICALS & INDUSTRIES share price has declined by 8.63% over the last six months and is down 21.03% on a year-on-year basis.

Share price over the last 1 day fell from 56.61 to 55.17, ranging between 53.43 and 57.69.
₹53.40
2.53% down today
₹57.69
1D LOW
1D HIGH

KREBS BIOCHEMICALS & INDUSTRIES Stock Insights

Stock Performance
OutperformingBeat Nifty by 10.96 % in last 3 month
KREBS BIOCHEMICALS & INDUSTRIES stock performance
Open₹56.61
High₹57.69
Low₹53.40
Prev. close₹56.60
KREBS BIOCHEMICALS & INDUSTRIES trading activity
Volume28,457
Average traded price₹54.67
Last traded time03:29:47 02 Nov
Last traded quantity16
Circuit
L
H
₹43.62
₹65.42
52-week
L
H
₹38.33
₹76.85
Mkt Cap Cr
125.83
P/E
-9.43
P/B
-0.53
ROA
-8.41%
ROE
7.82%
ROCE
-5.72%
Quick Ratio
0.03
EV/EBITDA
658.28

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Krebs Biochem has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Krebs Biochem appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

KREBS BIOCHEMICALS & INDUSTRIES Company Background

ISIN
INE268B01013
Sector Market Cap
₹ 125.83 Cr

Krebs Biochemicals & Industries Ltd is an India-based company, which is engaged in the business of manufacture of active pharmaceutical ingredients. The Company manufactures bulk active pharmaceutical ingredients, pharmaceutical intermediates, fine chemicals, nutraceuticals utilizing two revenue streams: contract manufacturing for large pharmaceutical and multinational companies, and development of its products for sale in global markets. Its products include Androstenedione, Lovastatin, and Simvastatin. The Company’s pilot or research and development stages products are Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan, and Phenylephrine. The Company has two manufacturing facilities one at Regadichelaka, Nellore District and another one at Kothapalli Village, Kasimkota Mandal, Visakhapatnam District, Andhra Pradesh, India.

KREBS BIOCHEMICALS & INDUSTRIES Financial Highlights

  • Revenue: KREBS BIOCHEMICALS & INDUSTRIES reported revenue of ₹25.76 crore in FY26 vs ₹44.02 crore in FY25. It showed a decrease of 41.48% on a yearly basis.
  • Operating Profit: KREBS BIOCHEMICALS & INDUSTRIES reported an operating loss of ₹16.93 crore in FY26 vs ₹26.92 crore in FY25. It showed an increase of 37.11% on a year-on-year basis.
  • Net Profit: KREBS BIOCHEMICALS & INDUSTRIES reported a net loss of ₹16.93 crore in FY26 vs ₹26.94 crore in FY25. It showed an increase of 37.16% on a yearly basis.

KREBS BIOCHEMICALS & INDUSTRIES Quarterly Result Highlights

  • KREBS BIOCHEMICALS & INDUSTRIES reported revenue of ₹5.83 crore in Sep 2026, compared with ₹7.14 crore in Jun 2026, representing a decrease of 18.35% on a quarter-on-quarter (QoQ) basis.
  • KREBS BIOCHEMICALS & INDUSTRIES reported an operating loss of ₹5.40 crore in Sep 2026, compared with ₹2.48 crore in Jun 2026, representing a decrease of 117.74% on a quarter-on-quarter (QoQ) basis.
  • KREBS BIOCHEMICALS & INDUSTRIES reported a loss of ₹5.40 crore in Sep 2026, compared with ₹2.48 crore in Jun 2026, reflecting a decrease of 117.74% on a QoQ basis.
  • The earnings per share (EPS) of KREBS BIOCHEMICALS & INDUSTRIES stood at ₹7.85 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
72.74%
FII
0.50%
Other DII
0.00%
Retail and other
26.76%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.49%
Mar 20260.50%
Jun 20260.50%
Sep 20260.50%

KREBS BIOCHEMICALS & INDUSTRIES Investment Returns

1 day
-3.67%
1 week
-12.38%
1 month
-19.88%
1 year
-21.03%
3 years
-24.59%
5 years
-67.45%

KREBS BIOCHEMICALS & INDUSTRIES Share Price History

KREBS BIOCHEMICALS & INDUSTRIES share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹56.61 / ₹54.52
-3.67%
30 Oct 26
₹56.60 / ₹56.60
-2.30%
29 Oct 26
₹59.95 / ₹57.93
-2.06%
28 Oct 26
₹59.49 / ₹59.15
-0.82%
Show more

KREBS BIOCHEMICALS & INDUSTRIES Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹23.73₹43.31₹50.42₹52.13
Other Income₹2.03₹0.71₹0.45₹0.62
Total Revenue₹25.76₹44.02₹50.87₹52.75
Total Expenses₹42.69₹70.94₹70.60₹77.45
Profit Before Tax-₹16.93-₹26.92-₹19.73-₹24.69
Tax₹0.00₹0.02₹0.00₹0.00
Profit After Tax-₹16.93-₹26.94-₹19.73-₹24.69
EPS - Basic-₹7.85-₹12.49-₹9.15-₹11.30
EPS - Diluted-₹7.85-₹12.49-₹9.15-₹11.30

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹16.93-₹26.92-₹19.73-₹24.69
Income before WC changes-₹3.04-₹14.51-₹7.84-₹14.87
Change in Assets₹0.44₹5.98-₹2.58₹19.12
Change in Liabilities₹0.69₹0.66₹12.79-₹28.96
Change in WC₹1.12₹6.64₹10.21-₹9.84
Cash flow from Operations-₹1.92-₹7.89₹2.36-₹24.71
Cash flow from Investing-₹3.64-₹4.97-₹7.82-₹12.65
Cash flow from Financing₹5.54₹12.86₹5.50₹37.34
Total Cash Flow-₹0.01₹0.00₹0.05-₹0.01
Cash (Start of the year)₹0.14₹0.14₹0.09₹0.10
Cash (End of the year)₹0.13₹0.14₹0.14₹0.09

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹153.62₹158.78₹160.73₹158.92
Current Assets₹9.62₹10.26₹17.44₹16.06
Total Assets₹163.25₹169.04₹178.17₹174.98
Current Liabilities₹113.07₹103.53₹61.83₹49.10
Net Current Asset-₹103.44-₹93.27-₹44.39-₹33.04
Non-Current Liabilities₹212.94₹211.75₹235.56₹225.34
Equity Capital-₹162.75-₹146.24-₹119.22-₹99.46
Total Equity & Liabilities₹163.25₹169.04₹178.17₹174.98
* All values are in INR Crore
KREBS BIOCHEMICALS & INDUSTRIES market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
KREBS BIOCHEMICALS & INDUSTRIES technical summary
Bearish indicators1
Neutral indicators6
Bullish indicators1
OverallNeutral
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
44.44
Neutral
ATR (14)
5.09
Neutral
STOCH(9,6)
23.53
Neutral
STOCH RSI (14)
32.12
Neutral
ADX(9)
17.6
Bullish
UO(9)
45.19
Neutral
ROC(12)
-9.75
Bearish
WillR(14)
-76.47
Neutral
Period
Simple value
Exponential vaue
5D
59.11
57.85
10D
57.9
58.06
20D
58.94
58.17
50D
57.41
57.81
100D
57.76
57.74
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct1L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

KREBS BIOCHEMICALS & INDUSTRIES
Pharmaceuticals
Add Stock
Add Another

KREBS BIOCHEMICALS & INDUSTRIES Returns Calculator

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

KREBS BIOCHEMICALS & INDUSTRIES Share Price FAQs

Please be aware that KREBS BIOCHEMICALS & INDUSTRIES stock prices are subject to continuous fluctuations due to various factors.